The pharmacological properties of seclazone (7-chloro-3,3a-dihydro-2H, 9H-isoxazolo (3,2-b) (1,3) benzoxazin-9-one) a new anti-inflammatory agent.
D000276:Adjuvants, Immunologic; D000418:Albumins / Q000302:isolation & purification; D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001168:Arthritis / Q000139:chemically induced / Q000188:drug therapy; D001583:Benzoxazoles / Q000627:therapeutic use; D001798:Blood Proteins / Q000032:analysis; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002351:Carrageenan; D004232:Diuretics / Q000494:pharmacology; D005340:Fibrinogen / Q000302:isolation & purification; D005916:Globulins / Q000302:isolation & purification; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007249:Inflammation / Q000139:chemically induced; D008297:Male; D010078:Oxazines / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D010080:Oxazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D013276:Stomach Ulcer / Q000139:chemically induced; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000418:Albumins; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D001583:Benzoxazoles; D001798:Blood Proteins; D004232:Diuretics; D005916:Globulins; D010078:Oxazines; D010080:Oxazoles; D002351:Carrageenan; D005340:Fibrinogen; D001920:Bradykinin